시장보고서
상품코드
1426133

세계 분석기기 시장 : 제품별, 용도별, 최종 사용자별, 지역별, 기회, 예측(2017년-2031년)

Analytical Instrumentation Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

발행일: | 리서치사: Market Xcel - Markets and Data | 페이지 정보: 영문 226 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

세계 분석기기 시장 규모는 예측기간 동안 복합 연간 성장률(CAGR) 5.69%를 나타낼 전망이며 2023년 601억 3,000만 달러에서 2031년에는 936억 2,000만 달러로 성장할 것으로 예측되고 있습니다. 세계 분석기기 시장의 성장은 만성질환과 감염증의 유병률 상승, 기술 진보, AI 통합, 다양한 분야에서의 품질관리의 중요성 증가, 환경문제, 헬스케어 투자 증가, 정부의 이니셔티브, 정책, 프로그램 등 다양한 요인에 의해 제공됩니다.

제약 회사 및 생명 공학 회사의 성장, 분석 시장에 대한 민간 및 공공 부문 투자 증가, 여러 주요 기업의 존재, 합병, 인수, 제휴, 신제품 출시 등의 개발 전략이 분석 장비 수요 가속화 하겠습니다. 세계 분석기기 시장은 전염병과 만성질환의 세계 확산으로 더욱 강력한 성장을 이루고 있습니다. 고령화 인구 증가는 여러 건강 상태에 대한 취약성으로 이어지며, 그 때문에 세계는 당뇨병, 암, 심혈관 질환 등의 만성 질환이나 감염증 환자 수의 영향을 받고 있습니다. 분석 장비는 의료 분야에서 중요한 역할을 하며, 질병 진단, 예방, 관리 및 제약 업계에서 원활한 창약에 매우 효율적입니다. 헬스케어 분야에서 최신의 고도의 분석기기 도입에 의한 헬스케어시설의 개선이나 식품가공연구소 및 화학연구소에서의 품질관리에 있어서 분석기기의 응용 확대 등 다른 요인이 세계 분석기기 시장 성장을 가속합니다.

고효율, 휴대용, 정교한 분석 장비 개발과 같은 기술 발전이 성장의 주요 요인입니다. 각국 정부는 의약 프로세스, 첨단 장비 및 계측의 품질을 향상시키기 위해 의료 분야에서 분석 장비의 사용을 장려하는 이니셔티브를 시작했습니다. 다양한 산업분야에서 분석기기의 광범위한 응용범위는 공개회사와 민간회사를 끌어들여 보다 효율적이고 효과적인 분석기기 개발을 위한 기술 혁신에 참여하고 투자하고 있습니다. 게다가, 분석 장비에 대한 건강 관리 산업 간의 합병, 인수, 제휴 및 협력은 세계 분석 장비 시장을 더욱 견인하고 있습니다.

본 보고서에서는 세계 분석기기 시장에 대해 조사했으며, 시장 개요와 함께 제품별, 용도별, 최종 사용자별, 지역별 동향 및 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 조사 방법

제2장 프로젝트의 범위와 정의

제3장 주요 요약

제4장 세계 분석기기 시장 전망(2017년-2031년)

  • 시장 규모와 예측
  • 제품별
  • 용도별
  • 최종 사용자별
  • 지역별
  • 기업별 시장 점유율(%)(2023년)

제5장 세계 분석기기 시장 전망, 지역별(2017년-2031년)

  • 북미
  • 유럽
  • 아시아태평양
  • 남미
  • 중동 및 아프리카

제6장 시장 매핑(2023년)

제7장 거시적 환경과 산업 구조

  • 수요 공급 분석
  • 수출입 분석
  • 밸류체인 분석
  • PESTEL 분석
  • Porter's Five Forces 분석

제8장 시장 역학

제9장 규제 프레임워크과 혁신

제10장 주요 진입기업의 정세

제11장 가격 분석

제12장 사례 연구

제13장 주요 기업의 전망

  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Waters Corporation
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • PerkinElmer AES
  • Mettler-Toledo International Inc
  • Shimadzu Scientific Instruments
  • Avantor, Inc.
  • Hitachi High-Tech Corporation

제14장 전략적 제안

제15장 문의와 면책사항

BJH 24.02.26

Global analytical instrumentation market is projected to witness a CAGR of 5.69% during the forecast period 2024-2031, growing from USD 60.13 billion in 2023 to USD 93.62 billion in 2031. Growth in global analytical instrumentation market is driven by various factors such as rising prevalence of chronic and infectious diseases, technological advancements, integration of AI, rising importance of quality control in various sectors, environmental concerns, increasing healthcare investments, government initiatives, policies, and programs.

Growing pharmaceuticals and biotechnological companies, increase in private and public sector investments in the analytics market, presence of several top players and developmental strategies like mergers, acquisitions, collaborations, and new product launches are accelerating the demand for analytical instrumentation. The global analytical instrumentation market is further undergoing robust growth due to the increasing prevalence of infectious and chronic diseases globally. The increasing aging population leads to vulnerability to several health conditions, due to which the world is affected by a high number of patients with chronic and infectious diseases such as diabetes, cancer, and cardiovascular diseases. Analytical instruments play a crucial role in the healthcare sector and are highly efficient in disease diagnosis, prevention, and control of several diseases and smooth drug discoveries in the pharmaceutical industry. Other factors, such as improvement in healthcare facilities by adopting the latest advanced analytical instrumentation in the healthcare sector and growing application of analytical instruments in quality control in food-processing laboratories and chemical laboratories, are driving the growth of the global analytical instrumentation market.

Technological advancements such as development of highly efficient, portable, and sophisticated analytical instruments is a major factor responsible for the growth. Governments have started initiatives to encourage the use of analytical instruments in the healthcare sector to bring quality in drug discovery process, advanced devices, and instrumentation. Wide range of application of analytical instruments in various industries, attracts public and private companies to join and invest in innovations for the development of more efficient and effective analytical instrument. Moreover, mergers and acquisitions, and partnerships and collaborations between the healthcare industries for analytical instrumentation is further driving the global analytical instrumentation market.

For instance, in January 2023, Agilent Technologies Inc. announced the acquisition of Avida Biomed, a life sciences company that works in genomics. The strategic acquisition would help Agilent develop precise cancer medicine and bring in-depth knowledge regarding various aspects of genomics.

Increasing Prevalence of Chronic Diseases

There has been a surge in demand for analytical instrumentation due to the rising number of chronic and infectious diseases worldwide. Analytical instruments play a crucial role in diagnosing health morbidities such as cancers, HIV, AIDS, and others. Analytical instruments such as biosensors are crucial in disease identification, prevention, rehabilitation, patient's health surveillance, and human health management.

As per WHO, non-communicable diseases (NCDs) kill 41 million people every year, which accounts for 74% of global deaths. The majority of NCD deaths, 17.9 million annually, are caused by cardiovascular diseases, which are followed by deaths by cancer (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million, including deaths from kidney disease caused by diabetes). The probability of death from a non-communicable disease increases with the consumption of tobacco, physical inactivity, alcohol consumption, and air pollution.

Technological Advancements

Artificial intelligence has revolutionized advancement in almost every sector. AI has huge potential in enhancing the analytical capabilities of the instruments used in different applications in healthcare. Over the past few years, there has been a surge of innovative product launches with AI capabilities, aimed at overcoming the limitations of existing analytical instruments for more in-depth quality analysis. These technological advancements increase the accuracy and speed of analytical instruments and improve the efficiency of the product. Due to it, many key market players are launching AI-based analytical instrumentation, to improve their product portfolio and provide better outcomes. Agilent Technologies Inc. announced the launch of LC/TQ and LC/Q-TOF Mass Spectrometry Solutions at ASMS 2023. Due to its increased efficiency and decreased instrument downtime, the 6495 LC/TQ instrument was designed with production-ready robustness for research purposes. With its completely new instrument architecture and intelligence, the Agilent Revident Quadrupole Time-of-Flight LC/MS (LC/QTOF) System maximizes operation time and productivity.

Growing Demand For Spectroscopy Instruments

Among the product segments, spectroscopy instruments hold the maximum market share in the global analytical instrumentation market. Extensive research and development activities and increased investments by key market players in this segment lead to huge demand for spectroscopy devices and instruments. Moreover, its potential to provide quantified information about the atoms and molecules is the main reason behind its increasing demand, especially in the chemical industry. Due to this, many key market players are including spectroscopy instruments in their product portfolio. For instance, in June 2023, Bruker Corporation announced the launch of the new "timsTOF Ultra mass spectrometer". At the single-cell level of 0.125 ng protein loading, at 1% FDR, the product can detect over 55K peptides that map into 5000 protein groups. Additionally, over 4800 protein groups can be measured at CVs of less than 20%. The product has set a new benchmark due to its high sensitivity and reliability. A supportive regulatory system enables analytical instrument manufacturers to invest and bring innovative launches.

Analytical Instruments Holds a Dominant Share in Life Sciences

In the application segment, life sciences hold a significant market share in the global analytical instrumentation market. Analytical instruments have a wide range of applications in almost every industry, such as food and beverages industry, chemical industry, environment analysis, and oil and refining industry, however, with increasing global aging population and the rising number of chronic and infectious diseases, the application of these instruments is increasing at a rapid scale in the healthcare sector. Moreover, key market players are bringing new product launches by developing innovative analytical instruments specially for their life sciences segment which is further accelerating the growth of this segment.

In May 2023, Thermo Fisher Scientific Inc. announced the launch of one of the most significant advanced mass spectrometry in 15 years, known as "Thermo Scientific Orbitrap Astral mass spectrometer". It will help identify clinical biomarkers, detect diseases early, and drive innovation in research and development activities.

Asia-Pacific is Expected to Grow at the Fastest Rate in the Forecast Period

Asia-Pacific is an emerging market that has huge potential for analytical instruments application in all sectors, due to which key market players are establishing manufacturing and operational facilities in this region to expand their business and overall size of the market. Rapidly increasing population and growing prevalence of chronic and infectious diseases in the region will accelerate the demand for highly efficient analytical instruments in the healthcare sector. Presence of countries such as China, Japan, India, South Korea, and Australia will strengthen the size of Asia-Pacific in the global analytical instrumentation market.

For instance, in August 2023, Agilent Technologies Inc., announced opening of a new full-scale integrated biology center at Monash University in Malaysia. The new facility will be equipped by various analytical instruments such as high-performing liquid chromatography, mass spectrometry, and gas chromatography systems, to provide analytical expertise in applied biology research and development and a wide range of applications in life science industry. Due to the growing interest of leading market players in investing resources in the region, Asia-Pacific is expected to grow faster than others.

Future Market Scenario (2024 - 2031F)

The global analytical instrumentation market is expected to grow in the forecast period, due to multiple factors. Primarily, the increasing prevalence of chronic and infectious diseases worldwide has increased the demand for analytical instruments in the healthcare industry. Growing environmental concerns, increased demand for quality control in the food and beverages industry, chemical laboratories, and oil refining industries, and demand for advanced analytical instruments further accelerate the growth of the market. Increasing investments in healthcare, collaborations between medical device and biotechnology companies, government initiatives, integration of AI with analytical instruments, increased research and development and new product launch by medical device companies are further driving the growth of global analytical instrumentation market.

Key Players Landscape and Outlook

In the global analytical instrumentation market, private companies consistently establish partnerships and distribution agreements. These alliances empower firms to gain from each other's strengths, benefit from access to new markets and technologies, and pool resources for research and development endeavors. Distribution agreements enable companies to broaden their market presence at a global level. These collaborative initiatives promote innovation, expedite product development and improve disease treatment.

In January 2023, Thermo Fisher Scientific Inc. announced the successful acquisition of The Binding Site Group, which is a global leader in the specialty diagnostics market. The acquisition aims to enhance and expand the company's existing specialty diagnostics portfolio by bringing innovation in diagnostics and monitoring for multiple myeloma, in its diagnostics segment. Along with improving medical treatment, the partnership aims to enhance in-depth knowledge, research and development activities, and innovative product launches to further expand the company's global presence in the global analytical instrumentation market.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Analytical Instrumentation Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product
    • 4.2.1. Chromatography Instruments
    • 4.2.2. Spectroscopy Instruments
    • 4.2.3. Molecular Analysis Instruments
    • 4.2.4. Electrochemical Analysis Instruments
    • 4.2.5. Particle Counters and Analyzers
    • 4.2.6. Others
  • 4.3. By Application
    • 4.3.1. Clinical Diagnostics
    • 4.3.2. Cancer and Genomic Research
    • 4.3.3. Life Sciences
    • 4.3.4. Drug Discovery
    • 4.3.5. Others
  • 4.4. By End-user
    • 4.4.1. Diagnostic Centers
    • 4.4.2. Research and Academic Institutes
    • 4.4.3. Pharmaceutical and Biotechnology Industry
    • 4.4.4. Others
  • 4.5. By Region
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia-Pacific
    • 4.5.4. South America
    • 4.5.5. Middle East and Africa
  • 4.6. By Company Market Share (%), 2023

5. Global Analytical Instrumentation Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product
      • 5.1.2.1. Chromatography Instruments
      • 5.1.2.2. Spectroscopy Instruments
      • 5.1.2.3. Molecular Analysis Instruments
      • 5.1.2.4. Electrochemical Analysis Instruments
      • 5.1.2.5. Particle Counters and Analyzers
      • 5.1.2.6. Others
    • 5.1.3. By Application
      • 5.1.3.1. Clinical Diagnostics
      • 5.1.3.2. Cancer and Genomic Research
      • 5.1.3.3. Life Sciences
      • 5.1.3.4. Drug Discovery
      • 5.1.3.5. Others
    • 5.1.4. By End-user
      • 5.1.4.1. Diagnostic Centers
      • 5.1.4.2. Research and Academic Institutes
      • 5.1.4.3. Pharmaceutical and Biotechnology Industry
      • 5.1.4.4. Others
    • 5.1.5. United States*
      • 5.1.5.1. Market Size & Forecast
      • 5.1.5.1.1. By Value
      • 5.1.5.1.2. By Volume
      • 5.1.5.2. By Product
      • 5.1.5.2.1. Chromatography Instruments
      • 5.1.5.2.2. Spectroscopy Instruments
      • 5.1.5.2.3. Molecular Analysis Instruments
      • 5.1.5.2.4. Electrochemical Analysis Instruments
      • 5.1.5.2.5. Particle Counters and Analyzers
      • 5.1.5.2.6. Others
      • 5.1.5.3. By Application
      • 5.1.5.3.1. Clinical Diagnostics
      • 5.1.5.3.2. Cancer and Genomic Research
      • 5.1.5.3.3. Life Sciences
      • 5.1.5.3.4. Drug Discovery
      • 5.1.5.3.5. Others
      • 5.1.5.4. By End-user
      • 5.1.5.4.1. Diagnostic Centers
      • 5.1.5.4.2. Research and Academic Institutes
      • 5.1.5.4.3. Pharmaceutical and Biotechnology Industry
      • 5.1.5.4.4. Others
    • 5.1.6. Canada
    • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product
  • 6.2. By Application
  • 6.3. By End-user
  • 6.4. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Thermo Fisher Scientific Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Agilent Technologies, Inc.
  • 13.3. Waters Corporation
  • 13.4. Danaher Corporation
  • 13.5. Bio-Rad Laboratories, Inc.
  • 13.6. Bruker Corporation
  • 13.7. PerkinElmer AES
  • 13.8. Mettler-Toledo International Inc
  • 13.9. Shimadzu Scientific Instruments
  • 13.10. Avantor, Inc.
  • 13.11. Hitachi High-Tech Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제